Skip to main content
Clinical Trials/NL-OMON33512
NL-OMON33512
Not yet recruiting
Not Applicable

Evaluation of the PulseCath, a Pulsatile Catheter Pump, in patients who need cardiac assist. - PulseCath 14 day study

PulseCath BV0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiogenic shock
Sponsor
PulseCath BV
Enrollment
20
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
PulseCath BV

Eligibility Criteria

Inclusion Criteria

  • Cardiac index (CI) \< 2\.2 L/min/m2, pre\-PulseCath, despite appropriate inotropic support and/or IABP
  • Mean arterial pressure (MAP) \< 60 mmHg, pre\-PulseCath, despite appropriate inotropic support and/or IABP
  • Expected duration of support by the PulseCath: 24 hours to 14 days
  • Patient older than 18 years
  • Patient or legal representative has signed the Informed Consent

Exclusion Criteria

  • Aortic disease: ascending aortic aneurism, severe calcified aorta
  • Aortic valvular disease: aortic valve stenosis, aortic valve insufficiency
  • Aortic valve prosthesis
  • Subclavian artery stenosis in case of insertion via subclavian artery
  • Thrombus in left ventricle
  • No residual function of the left ventricle
  • No functioning right ventricle
  • History of coagulation disorders
  • Previous history of CVA within the last 12 months
  • Liver dysfunction, evidenced by: ALT \> 100 U/L (men) \> 70 U/L (women) or AST \> 100 U/L (men) \> 70 U/L (women)

Outcomes

Primary Outcomes

Not specified

Similar Trials